choline has been researched along with Bone Cancer in 90 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-six patients with painful, bony metastases were recruited into a randomized, double-blind, single dose, two-treatment, three-part crossover study of choline magnesium trisalicylate (CMT) and placebo." | 9.07 | The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study. ( Johnson, JR; Miller, AJ, 1994) |
| "The present study was conducted to compare the diagnostic accuracy between carbon-11 choline (11C-choline) positron emission tomography (PET)/computed tomography (CT) and conventional imaging for the staging of bone and soft tissue sarcomas." | 7.73 | Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging. ( Arai, Y; Kakizoe, T; Kawai, A; Maeda, T; Moriyama, N; Seki, K; Tateishi, U; Terauchi, T; Yamaguchi, U, 2006) |
| "Viable bone metastases and osteoblastic change induced by the treatment effect were identified in 53 (94." | 5.62 | Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT. ( Hanasaki, T; Kanematsu, A; Kawanaka, Y; Kitajima, K; Komoto, H; Nagasawa, S; Shimatani, K; Taguchi, M; Yamada, Y; Yamakado, K; Yamamoto, S, 2021) |
| "Twenty-six patients with painful, bony metastases were recruited into a randomized, double-blind, single dose, two-treatment, three-part crossover study of choline magnesium trisalicylate (CMT) and placebo." | 5.07 | The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study. ( Johnson, JR; Miller, AJ, 1994) |
| "The present study was conducted to compare the diagnostic accuracy between carbon-11 choline (11C-choline) positron emission tomography (PET)/computed tomography (CT) and conventional imaging for the staging of bone and soft tissue sarcomas." | 3.73 | Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging. ( Arai, Y; Kakizoe, T; Kawai, A; Maeda, T; Moriyama, N; Seki, K; Tateishi, U; Terauchi, T; Yamaguchi, U, 2006) |
| "Musculoskeletal tumors comprise a multitude of tumor entities with different grades of malignancy, biological behavior, and therapeutic options." | 2.50 | PET tracers in musculoskeletal disease beyond FDG. ( Benz, MR; Buck, AK; Herrmann, K; Pomykala, KL; Wieder, HA, 2014) |
| "In patients with a high risk of distant metastases and suitable for systemic salvage therapy, a positive lesion must be obviously visualized with one of the currently available imaging techniques." | 2.49 | The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques? ( Borghesi, M; Brunocilla, E; Castellucci, P; Ceci, F; Fanti, S; Gacci, M; Martorana, G; Nanni, C; Schiavina, R; Vagnoni, V, 2013) |
| "Viable bone metastases and osteoblastic change induced by the treatment effect were identified in 53 (94." | 1.62 | Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT. ( Hanasaki, T; Kanematsu, A; Kawanaka, Y; Kitajima, K; Komoto, H; Nagasawa, S; Shimatani, K; Taguchi, M; Yamada, Y; Yamakado, K; Yamamoto, S, 2021) |
| "Forty-nine consecutive prostate cancer patients diagnosed with oligometastatic recurrence on Ch-PET have been prospectively treated." | 1.51 | Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT. ( Ahtamon, A; Bilbao, P; Cacicedo, J; Casquero Ocio, F; Fernandez, I; Garcia-Olaverri, J; Gomez-Iturriaga, A; Llarena, R; Ortiz de Zarate, R; Ost, P; Rodeño, E, 2019) |
| "A 76-year-old man with metastatic prostate cancer and back pain was referred for palliative radiotherapy." | 1.48 | Prostate Cancer Lytic Bone Metastases Imaged With 18F-Fluorocholine PET/CT. ( Alabed, YZ, 2018) |
| "56 patients diagnosed with prostate cancer underwent 99mTc-methylendiphosphonates bone scintigraphy (99mTc-MDP-BS) and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) or fluorine-18-fluorocholine PET/CT (18F-FCH-PET/CT) within six weeks." | 1.48 | Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy? ( Cholewinski, W; Czepczynski, R; Pietrzak, AK; Wierzchoslawska, E, 2018) |
| "Twenty Japanese prostate cancer patients underwent 11C-choline and FDG PET/CT before (n=5) or after (n=15) treatment." | 1.48 | Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer. ( Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S, 2018) |
| "An 84-year-old man with a history of prostate cancer, treated with radiotherapy, presented with an increase in PSA levels." | 1.46 | Internal Auditory Canal Tumor as an Incidental Finding on a Choline PET/CT Scan in a Prostate Cancer Patient. ( Efthymiadou, R; Malamitsi, J; Pipikos, T; Prassopoulos, V; Vlachou, F, 2017) |
| "F-choline PET/CT was performed for suspected prostate cancer relapse in a 67-year-old man with hip pain and a rapid rise in prostate-specific antigen values (1." | 1.43 | 18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection. ( Castellani, M; Cortelezzi, A; Florimonte, L; Longari, V; Orunesu, E, 2016) |
| "In two cases history of a second malignancy (lung cancer and cutaneous basocellular carcinoma) was known (diagnosed 12 and 6 years after PCa, respectively)." | 1.43 | Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series. ( Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A, 2016) |
| "multi-parametric MRI in the prostate cancer relapse." | 1.42 | (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer. ( Cozar, M; Escobar, M; Garcia, JR; Moragas, M; Romera, N; Soler, M, 2015) |
| "In the initial staging of high-risk prostate cancer, metastatic nodes could be detected if there are more than 5 mm, especially those localized outside the lymphadenectomy area." | 1.40 | [Focus: Prostate cancer and PET-choline]. ( Brenot-Rossi, I, 2014) |
| "Fifty-five patients with biopsy-proven prostate cancer or suspected recurrent prostate cancer were examined with simultaneous [18F] choline Positron emission tomography (PET)/MRI at 3 T." | 1.40 | Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis. ( Heusch, P; Lauenstein, TC; Lipponer, C; Nagarajah, J; Nensa, F; Pöppel, TD; Rübben, H; Schlosser, TW; Wetter, A, 2014) |
| "Choline was only found in six benign lesions." | 1.39 | Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors. ( Cheng, K; Cheng, X; Ding, Y; Liang, W; Vanel, D; Zhang, J, 2013) |
| "Patients with prostate cancer with prostate specific antigen (PSA) levels between 20 and 99 ng/mL and/or Gleason score 8-10 tumours, planned for treatment with curative intent based on routine staging with a negative or inconclusive bone scan, were further investigated with a (18)F-fluorocholine and a (18)F-fluoride PET/CT." | 1.38 | Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer. ( Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T, 2012) |
| "Choline SNRs were different for malignant and benign lesions (11." | 1.34 | Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. ( Barker, PB; Bluemke, DA; Eng, J; Fayad, LM; Jacobs, MA; Kulesza, P; Weber, KL, 2007) |
| "Choline was detected in 18 of 19 patients with malignant tumors and in three of 17 patients with benign lesions." | 1.32 | Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. ( Chien, SH; Hsieh, TJ; Li, CW; Liu, GC; Tsai, KB; Wang, CK, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.11) | 18.7374 |
| 1990's | 1 (1.11) | 18.2507 |
| 2000's | 22 (24.44) | 29.6817 |
| 2010's | 60 (66.67) | 24.3611 |
| 2020's | 6 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Faudemer, J | 1 |
| Meriaux, E | 1 |
| Tillou, X | 1 |
| Aide, N | 1 |
| Filippi, L | 1 |
| Basile, P | 1 |
| Schillaci, O | 2 |
| Bagni, O | 1 |
| de Leiris, N | 2 |
| Leenhardt, J | 1 |
| Boussat, B | 1 |
| Montemagno, C | 1 |
| Seiller, A | 1 |
| Phan Sy, O | 1 |
| Roux, J | 1 |
| Laramas, M | 2 |
| Verry, C | 1 |
| Iriart, C | 1 |
| Fiard, G | 1 |
| Long, JA | 1 |
| Descotes, JL | 1 |
| Vuillez, JP | 1 |
| Riou, L | 2 |
| Djaileb, L | 2 |
| Ruggeri, V | 1 |
| Amrane, K | 1 |
| Le Pennec, R | 1 |
| Tissot, V | 1 |
| Schick, U | 1 |
| Abgral, R | 1 |
| Kitajima, K | 3 |
| Yamamoto, S | 3 |
| Kawanaka, Y | 1 |
| Komoto, H | 1 |
| Shimatani, K | 1 |
| Hanasaki, T | 1 |
| Taguchi, M | 2 |
| Nagasawa, S | 1 |
| Yamada, Y | 3 |
| Kanematsu, A | 3 |
| Yamakado, K | 3 |
| Haroon, A | 1 |
| Syed, R | 1 |
| Endozo, R | 1 |
| Allie, R | 1 |
| Freeman, A | 1 |
| Emberton, M | 1 |
| Bomanji, J | 1 |
| Lapa, P | 1 |
| Saraiva, T | 1 |
| Silva, R | 1 |
| Marques, M | 1 |
| Costa, G | 1 |
| Lima, JP | 1 |
| García Vicente, AM | 1 |
| Soriano Castrejón, Á | 1 |
| Alvarez Cabellos, R | 1 |
| Sanchez Gil, B | 1 |
| Mohedano Mohedano, N | 1 |
| Incerti, E | 1 |
| Gangemi, V | 1 |
| Mapelli, P | 1 |
| Deantoni, CL | 1 |
| Giovacchini, G | 3 |
| Fallanca, F | 2 |
| Fodor, A | 1 |
| Ciarmiello, A | 1 |
| Baldari, S | 1 |
| Gianolli, L | 3 |
| Di Muzio, N | 1 |
| Picchio, M | 3 |
| Malamitsi, J | 1 |
| Efthymiadou, R | 1 |
| Pipikos, T | 1 |
| Vlachou, F | 1 |
| Prassopoulos, V | 1 |
| Bongiovanni, A | 1 |
| Recine, F | 1 |
| Celli, M | 1 |
| Marcantognini, G | 1 |
| Foca, F | 1 |
| Liverani, C | 1 |
| Fausti, V | 1 |
| De Vita, A | 1 |
| Miserocchi, G | 1 |
| Mercatali, L | 1 |
| Amadori, D | 1 |
| Ibrahim, T | 1 |
| Dyrberg, E | 1 |
| Larsen, EL | 1 |
| Hendel, HW | 1 |
| Thomsen, HS | 1 |
| Alabed, YZ | 1 |
| Pietrzak, AK | 1 |
| Czepczynski, R | 1 |
| Wierzchoslawska, E | 1 |
| Cholewinski, W | 1 |
| Vija Racaru, L | 1 |
| Sinigaglia, M | 1 |
| Kanoun, S | 1 |
| Ben Bouallègue, F | 1 |
| Tal, I | 1 |
| Brillouet, S | 1 |
| Bauriaud-Mallet, M | 1 |
| Zerdoud, S | 1 |
| Dierickx, L | 1 |
| Vallot, D | 1 |
| Caselles, O | 1 |
| Gabiache, E | 1 |
| Pascal, P | 1 |
| Courbon, F | 1 |
| Odawara, S | 1 |
| Kobayashi, K | 1 |
| Fujiwara, M | 1 |
| Kamikonya, N | 1 |
| Fukushima, K | 1 |
| Nakanishi, Y | 2 |
| Hashimoto, T | 2 |
| Suzuki, T | 2 |
| Nojima, M | 2 |
| Guo, Y | 1 |
| Wang, L | 1 |
| Hu, J | 1 |
| Feng, D | 1 |
| Xu, L | 1 |
| Oshima, K | 1 |
| Go, S | 1 |
| Trump, T | 1 |
| Luchey, AM | 1 |
| Hogg, J | 1 |
| Mattes, MD | 1 |
| Mujukian, A | 1 |
| Kay, M | 1 |
| Scimeca, M | 1 |
| Urbano, N | 1 |
| Bonfiglio, R | 1 |
| Mapelli, SN | 1 |
| Catapano, CV | 1 |
| Carbone, GM | 1 |
| Ciuffa, S | 1 |
| Tavolozza, M | 1 |
| Mauriello, A | 1 |
| Bonanno, E | 1 |
| Gomez-Iturriaga, A | 1 |
| Casquero Ocio, F | 1 |
| Ost, P | 1 |
| Fernandez, I | 1 |
| Rodeño, E | 1 |
| Llarena, R | 1 |
| Garcia-Olaverri, J | 1 |
| Ortiz de Zarate, R | 1 |
| Cacicedo, J | 1 |
| Ahtamon, A | 1 |
| Bilbao, P | 1 |
| Zhou, J | 1 |
| Gou, Z | 1 |
| Wu, R | 1 |
| Yuan, Y | 1 |
| Yu, G | 1 |
| Zhao, Y | 1 |
| Cuccurullo, V | 2 |
| Cascini, GL | 1 |
| Tamburrini, O | 2 |
| Rotondo, A | 2 |
| Mansi, L | 2 |
| Schiavina, R | 4 |
| Ceci, F | 2 |
| Borghesi, M | 1 |
| Brunocilla, E | 2 |
| Vagnoni, V | 1 |
| Gacci, M | 1 |
| Castellucci, P | 4 |
| Nanni, C | 2 |
| Martorana, G | 3 |
| Fanti, S | 4 |
| Wondergem, M | 1 |
| van der Zant, FM | 1 |
| van der Ploeg, T | 1 |
| Knol, RJ | 1 |
| Wetter, A | 2 |
| Lipponer, C | 2 |
| Nensa, F | 2 |
| Heusch, P | 2 |
| Rübben, H | 2 |
| Altenbernd, JC | 1 |
| Schlosser, T | 1 |
| Bockisch, A | 1 |
| Pöppel, T | 1 |
| Lauenstein, T | 1 |
| Nagarajah, J | 2 |
| Brenot-Rossi, I | 1 |
| Treglia, G | 1 |
| Ceriani, L | 1 |
| Barizzi, J | 1 |
| Paone, G | 1 |
| Giovanella, L | 1 |
| Schlosser, TW | 1 |
| Pöppel, TD | 1 |
| Lauenstein, TC | 1 |
| Wieder, HA | 1 |
| Pomykala, KL | 1 |
| Benz, MR | 1 |
| Buck, AK | 1 |
| Herrmann, K | 2 |
| De Bari, B | 1 |
| Alongi, F | 1 |
| Lestrade, L | 1 |
| Giammarile, F | 1 |
| Shen, G | 1 |
| Deng, H | 1 |
| Hu, S | 1 |
| Jia, Z | 1 |
| Garcia, JR | 3 |
| Jorcano, S | 1 |
| Soler, M | 4 |
| Linero, D | 1 |
| Moragas, M | 4 |
| Riera, E | 3 |
| Miralbell, R | 1 |
| Lomeña, F | 3 |
| Balogova, S | 3 |
| Zakoun, JB | 1 |
| Michaud, L | 1 |
| Khalil, A | 1 |
| Tassart, M | 1 |
| Esteso, A | 1 |
| Kerrou, K | 4 |
| Huchet, V | 3 |
| Carette, MF | 1 |
| Lotz, JP | 1 |
| Talbot, JN | 4 |
| Goldstein, J | 1 |
| Even-Sapir, E | 1 |
| Ben-Haim, S | 1 |
| Saad, A | 1 |
| Spieler, B | 1 |
| Davidson, T | 1 |
| Berger, R | 1 |
| Weiss, I | 1 |
| Appel, S | 1 |
| Lawrence, YR | 1 |
| Symon, Z | 1 |
| Romera, N | 1 |
| Cozar, M | 1 |
| Escobar, M | 1 |
| Tabrizipour, AI | 1 |
| Dunne, M | 1 |
| Evangelista, L | 1 |
| Cimitan, M | 1 |
| Zattoni, F | 2 |
| Guttilla, A | 1 |
| Saladini, G | 1 |
| Koo, PJ | 1 |
| David Crawford, E | 1 |
| Graziani, T | 1 |
| Chondrogiannis, S | 1 |
| Bonfiglioli, R | 1 |
| Costa, S | 1 |
| Virgolini, IJ | 1 |
| Rubello, D | 2 |
| Colletti, PM | 1 |
| Maines, F | 1 |
| Caffo, O | 1 |
| Donner, D | 1 |
| Sperduti, I | 1 |
| Bria, E | 1 |
| Veccia, A | 1 |
| Chierichetti, F | 1 |
| Tortora, G | 1 |
| Galligioni, E | 1 |
| Florimonte, L | 1 |
| Orunesu, E | 1 |
| Castellani, M | 1 |
| Longari, V | 1 |
| Cortelezzi, A | 1 |
| Zanoni, L | 1 |
| Pultrone, C | 1 |
| Lodi, F | 1 |
| Malizia, C | 1 |
| Ferrari, M | 1 |
| Rigatti, P | 1 |
| Fonti, C | 1 |
| Doyle-Lindrud, S | 1 |
| Azad, GK | 1 |
| Cook, GJ | 1 |
| Schwenck, J | 1 |
| Rempp, H | 1 |
| Reischl, G | 1 |
| Kruck, S | 1 |
| Stenzl, A | 1 |
| Nikolaou, K | 1 |
| Pfannenberg, C | 1 |
| la Fougère, C | 1 |
| Sollini, M | 1 |
| Pasqualetti, F | 1 |
| Perri, M | 1 |
| Coraggio, G | 1 |
| Roncali, M | 1 |
| Boni, R | 1 |
| Lazzeri, E | 1 |
| Galeandro, M | 1 |
| Paiar, F | 1 |
| Versari, A | 1 |
| Erba, PA | 1 |
| Scalzi, P | 1 |
| Baiocco, C | 1 |
| Genovese, S | 1 |
| Trevisan, A | 1 |
| Sirotova, Z | 1 |
| Poti, C | 1 |
| Parker, WP | 1 |
| Evans, JD | 1 |
| Stish, BJ | 1 |
| Park, SS | 1 |
| Olivier, K | 1 |
| Choo, R | 1 |
| Nathan, MA | 1 |
| Welch, BT | 1 |
| Karnes, RJ | 1 |
| Mynderse, LA | 1 |
| Pisansky, TM | 1 |
| Kwon, ED | 1 |
| Lowe, VJ | 1 |
| Davis, BJ | 1 |
| Tuncel, M | 1 |
| Souvatzoglou, M | 1 |
| Stollfuss, J | 1 |
| Schuster, T | 1 |
| Weirich, G | 1 |
| Wester, HJ | 1 |
| Schwaiger, M | 1 |
| Krause, BJ | 1 |
| Luboldt, W | 1 |
| Küfer, R | 1 |
| Blumstein, N | 1 |
| Toussaint, TL | 1 |
| Kluge, A | 1 |
| Seemann, MD | 1 |
| Luboldt, HJ | 1 |
| Samanes Gajate, AM | 1 |
| Messa, C | 3 |
| Fazio, F | 2 |
| Lindholm, P | 1 |
| Seppänen, M | 1 |
| Minn, H | 1 |
| Kwee, SA | 1 |
| Coel, MN | 1 |
| Ly, BH | 1 |
| Lim, J | 1 |
| Lecouvet, FE | 1 |
| Vande Berg, BC | 1 |
| Malghem, J | 1 |
| Omoumi, P | 1 |
| Simoni, P | 1 |
| Fuccio, C | 1 |
| Santi, I | 1 |
| Allegri, V | 1 |
| Pettinato, V | 1 |
| Boschi, S | 1 |
| Al-Nahhas, A | 1 |
| Doganay, S | 1 |
| Altinok, T | 1 |
| Alkan, A | 1 |
| Kahraman, B | 1 |
| Karakas, HM | 1 |
| Muacevic, A | 1 |
| Kufeld, M | 1 |
| Rist, C | 1 |
| Wowra, B | 1 |
| Stief, C | 1 |
| Staehler, M | 1 |
| Cascini, G | 1 |
| Rossi, A | 1 |
| Langsteger, W | 5 |
| Beheshti, M | 4 |
| Paycha, F | 1 |
| Egrot, C | 1 |
| Janetschek, G | 1 |
| Loidl, W | 2 |
| Nataf, V | 1 |
| Pascal, O | 1 |
| Cussenot, O | 2 |
| Tian, M | 3 |
| Zhang, H | 3 |
| Endo, K | 3 |
| Zengerling, F | 1 |
| Schrader, AJ | 1 |
| Schrader, M | 1 |
| Jentzmik, F | 1 |
| Spinapolice, EG | 1 |
| Crivellaro, C | 1 |
| Zhang, J | 1 |
| Cheng, K | 1 |
| Ding, Y | 2 |
| Liang, W | 1 |
| Vanel, D | 1 |
| Cheng, X | 1 |
| Subhawong, TK | 1 |
| Wang, X | 1 |
| Durand, DJ | 1 |
| Jacobs, MA | 3 |
| Carrino, JA | 1 |
| Machado, AJ | 1 |
| Fayad, LM | 4 |
| Kjölhede, H | 1 |
| Ahlgren, G | 1 |
| Almquist, H | 1 |
| Liedberg, F | 1 |
| Lyttkens, K | 1 |
| Ohlsson, T | 1 |
| Bratt, O | 1 |
| Poulsen, MH | 1 |
| Bouchelouche, K | 1 |
| Høilund-Carlsen, PF | 1 |
| Petersen, H | 1 |
| Gerke, O | 1 |
| Steffansen, SI | 1 |
| Marcussen, N | 1 |
| Svolgaard, N | 1 |
| Vach, W | 1 |
| Geertsen, U | 1 |
| Walter, S | 1 |
| Valls, E | 2 |
| Garcia, G | 1 |
| Bassa, P | 1 |
| Landoni, C | 1 |
| Matarrese, M | 1 |
| De Cobelli, F | 1 |
| Maschio, AD | 1 |
| Oriuchi, N | 2 |
| Higuchi, T | 2 |
| Watanabe, H | 1 |
| Aoki, J | 1 |
| Tanada, S | 1 |
| Wang, CK | 1 |
| Li, CW | 1 |
| Hsieh, TJ | 1 |
| Chien, SH | 1 |
| Liu, GC | 1 |
| Tsai, KB | 1 |
| Bluemke, DA | 3 |
| McCarthy, EF | 1 |
| Weber, KL | 2 |
| Barker, PB | 3 |
| Heinisch, M | 1 |
| Fogelman, I | 1 |
| Yoshida, S | 1 |
| Nakagomi, K | 1 |
| Goto, S | 1 |
| Futatsubashi, M | 1 |
| Torizuka, T | 1 |
| Tateishi, U | 1 |
| Yamaguchi, U | 1 |
| Maeda, T | 1 |
| Seki, K | 1 |
| Terauchi, T | 1 |
| Kawai, A | 1 |
| Arai, Y | 1 |
| Moriyama, N | 1 |
| Kakizoe, T | 1 |
| Gutman, F | 2 |
| Aflalo-Hazan, V | 1 |
| Montravers, F | 2 |
| Grahek, D | 2 |
| Vali, R | 2 |
| Eng, J | 1 |
| Kulesza, P | 1 |
| Kerrouche, N | 1 |
| Gattegno, B | 1 |
| Thibault, P | 1 |
| Sah, PL | 1 |
| Sharma, R | 1 |
| Kandpal, H | 1 |
| Seith, A | 1 |
| Rastogi, S | 1 |
| Bandhu, S | 1 |
| Jagannathan, NR | 1 |
| Waldenberger, P | 1 |
| Fitz, F | 1 |
| Nader, M | 1 |
| Broinger, G | 1 |
| Stoiber, F | 1 |
| Foglman, I | 1 |
| Johnson, JR | 1 |
| Miller, AJ | 1 |
| Singh, AT | 1 |
| Radeff, JM | 1 |
| Kunnel, JG | 1 |
| Stern, PH | 1 |
| Potter, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies[NCT05597215] | 70 participants (Anticipated) | Observational | 2022-12-31 | Not yet recruiting | |||
| All-in-One Prostate Cancer Staging With MRI[NCT06071195] | 400 participants (Anticipated) | Observational | 2021-12-22 | Recruiting | |||
| PRISMA-PET - Primary Staging of Prostate Cancer: A Randomized Controlled Trial Comparing 18F-PSMA-1007 PET/CT to Conventional Imaging[NCT05123300] | 448 participants (Anticipated) | Interventional | 2021-10-04 | Recruiting | |||
| Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) PET/CT Utilizing the High Resolution Digital Philips Vereos Scanner, in Patients With Biochemical Recurrence After Radical Prostatectomy[NCT04234399] | 22 participants (Actual) | Observational | 2020-03-01 | Active, not recruiting | |||
| A Multi-center, Open-label, Single Arm Phase III Clinical Trial for the Diagnostic Efficacy Assessment and Safety Evaluation by [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer[NCT05936658] | Phase 3 | 89 participants (Anticipated) | Interventional | 2023-05-08 | Recruiting | ||
| Evaluation of [18F] Fluorocholine PET/CT for Detection of Regional Lymph Node Metastases From Prostate Cancer[NCT00670527] | 205 participants (Anticipated) | Interventional | 2008-01-31 | Recruiting | |||
| Multi-paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases[NCT04626206] | 12 participants (Anticipated) | Observational | 2020-12-31 | Not yet recruiting | |||
| F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer Treated by Abiraterone Acetate or Enzalutamide[NCT01981707] | Phase 2/Phase 3 | 12 participants (Actual) | Interventional | 2013-12-31 | Terminated (stopped due to enrollment default) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for choline and Bone Cancer
| Article | Year |
|---|---|
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature.
Topics: Aged; Bone Neoplasms; Choline; Humans; Ilium; Male; Neuroendocrine Tumors; Organometallic Compounds; | 2017 |
Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic N | 2018 |
Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis.
Topics: Bone Neoplasms; Choline; Gallium Isotopes; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging | 2019 |
Bone metastases radiopharmaceuticals: an overview.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Fluorine Rad | 2013 |
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?
Topics: Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Fluorine Radioisotope | 2013 |
A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer.
Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorides; Fluorine Radioisotopes; Humans; Male; Mult | 2013 |
PET tracers in musculoskeletal disease beyond FDG.
Topics: Amino Acids; Bone Diseases; Bone Neoplasms; Carbon Radioisotopes; Choline; Dideoxynucleosides; Fluor | 2014 |
Choline-PET in prostate cancer management: the point of view of the radiation oncologist.
Topics: Biomarkers, Tumor; Bone Neoplasms; Choline; Gamma Rays; Humans; Male; Neoplasm Recurrence, Local; Po | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari | 2014 |
¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Multimodal Imag | 2014 |
New Positron-Emission Tomography/Computed Tomography Imaging for Bone Metastases
.
Topics: Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm | 2016 |
Multi-technique imaging of bone metastases: spotlight on PET-CT.
Topics: Bone Neoplasms; Choline; Contrast Media; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Im | 2016 |
Pathophysiological premises to radiotracers for bone metastases.
Topics: Bone and Bones; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Humans; Iodine Radi | 2011 |
[Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Disease Progression; Fluorine Radioisotopes; Humans; | 2012 |
Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions.
Topics: Algorithms; Biomarkers, Tumor; Bone Neoplasms; Choline; Contrast Media; Humans; Image Interpretation | 2012 |
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeo | 2006 |
[Clinical usefulness of positron emission tomography in prostate cancer].
Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recu | 2007 |
Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.
Topics: Bone Neoplasms; Choline; Creatine; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Proton | 2007 |
Immunoglobulin-producing tumors and myeloma proteins of mice.
Topics: Amino Acid Sequence; Amyloidosis; Animals; Antigens, Neoplasm; Antigens, Viral; Bence Jones Protein; | 1972 |
6 trials available for choline and Bone Cancer
| Article | Year |
|---|---|
Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Positron Emission Tomog | 2017 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan | 2016 |
(18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Case-Control Studies; Choline; Hormones; Humans; Male; Midd | 2009 |
Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Carbon Radioisotopes; C | 2004 |
Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.
Topics: Adult; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; | 2008 |
The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Choline; Dose-Resp | 1994 |
65 other studies available for choline and Bone Cancer
| Article | Year |
|---|---|
Normalization of Liver Physiological Uptake as a Response Marker to Treatment in Prostate Cancer Liver Metastases Appearing as Photopenic on Baseline 18F-Fluorocholine PET/CT.
Topics: Bone Neoplasms; Choline; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Co | 2023 |
The Relationship Between Total Lesion Activity on
Topics: Aged; Aged, 80 and over; Alpha Particles; Bone and Bones; Bone Neoplasms; Choline; Feasibility Studi | 2020 |
Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomo | 2020 |
Aggressive Bone Metastatic Prostate Cancer With Periosteal Reaction in 18F-Choline PET/CT.
Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Osteogenesis; Positron Emission Tomography Computed Tom | 2021 |
Incidental Findings of a Vestibular Schwannoma on 18F-Choline PET/CT.
Topics: Aged; Bone Neoplasms; Brain; Choline; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; | 2021 |
Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Neoplasm Metasta | 2021 |
[Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18; | 2017 |
Response Assessment of 223Ra Treatment: Should a Fluorocholine PET/CT Be Performed?
Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Prost | 2017 |
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis | 2017 |
Internal Auditory Canal Tumor as an Incidental Finding on a Choline PET/CT Scan in a Prostate Cancer Patient.
Topics: Aged, 80 and over; Bone Neoplasms; Choline; Humans; Incidental Findings; Male; Neuroma, Acoustic; Po | 2017 |
Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Middle A | 2018 |
Prostate Cancer Lytic Bone Metastases Imaged With 18F-Fluorocholine PET/CT.
Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Neoplasm Staging; Palliative Care; Positron Emission To | 2018 |
Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hu | 2018 |
Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.
Topics: Aged; Aged, 80 and over; Blood; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Pilot Projects; | 2018 |
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma | 2018 |
[The Usefulness of 11C-Choline PET/CT for Detecting Metastasis and Treatment Monitoring of Renal Cell Carcinoma : Report of Two Cases].
Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Carcinoma, Renal Cell; Choline; Humans; Kidney Neoplasms | 2018 |
Intramedullary Reactive Fibrosis as Mimic of Prostate Cancer Bone Metastasis on 11C-Choline Positron Emission and Computed Tomography.
Topics: Bone and Bones; Bone Neoplasms; Carbon Radioisotopes; Choline; Fibrosis; Humans; Male; Middle Aged; | 2019 |
Indeterminate single bone lesion on multimodality imaging of prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; Diagnosis, Differential; Diphosphonates; Disease Prog | 2019 |
Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients.
Topics: Bone Neoplasms; Calcification, Physiologic; Calcinosis; Cell Differentiation; Cell Shape; Choline; E | 2018 |
Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Carcinoma; Choline; Fluori | 2019 |
Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CT.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance I | 2014 |
[Focus: Prostate cancer and PET-choline].
Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Prostat | 2014 |
Colorectal carcinoma with bone metastases detected by 18F-choline PET/CT.
Topics: Aged; Biopsy; Bone Neoplasms; Choline; Colorectal Neoplasms; Humans; Male; Multimodal Imaging; Posit | 2014 |
Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis.
Topics: Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffus | 2014 |
11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning.
Topics: Aged; Biopsy; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Mid | 2015 |
Whole-body 18F-fluorocholine (FCH) PET/CT and MRI of the spine for monitoring patients with castration-resistant prostate cancer metastatic to bone: a pilot study.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Magnetic Resonance | 2014 |
Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Brachytherapy; Carbon Radioisotopes; Choline; Humans; Lymph | 2017 |
(11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carbon Radioisotopes; Choline; Combined Modality Therapy; Humans; Ly | 2015 |
The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer: a case of osteolytic prostate metastasis.
Topics: Adenocarcinoma; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emi | 2015 |
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A
Topics: Abdomen; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Lymph Nod | 2015 |
11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; M | 2015 |
Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Bone Neoplasms; Choli | 2016 |
18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection.
Topics: Aged; Bone Neoplasms; Carcinoma; Choline; Humans; Incidental Findings; Male; Multiple Myeloma; Posit | 2016 |
Comparison of
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotop | 2017 |
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung | 2016 |
Evaluation of bone metastases by 18F-choline PET/CT in a patient with castration-resistant prostate cancer treated with radium-223.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Positron Emissi | 2017 |
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.
Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged | 2017 |
[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; N | 2008 |
Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance | 2008 |
Increased C-11 choline uptake in pagetic bone in a patient with coexisting skeletal metastases from prostate cancer.
Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Cell Proliferation; Choline; Diagnosis, Differential; Fe | 2008 |
The role of PET/CT and current challenges in prostate cancer management.
Topics: Acetates; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Posit | 2009 |
Diffusion-weighted MR imaging: adjunct or alternative to T1-weighted MR imaging for prostate carcinoma bone metastases?
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance | 2009 |
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; N | 2010 |
The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Choline; Contrast Media; Diagnosis, Differential; Female; G | 2011 |
Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Feasibility Studies; Fluorine Radioisotopes; Follo | 2013 |
Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; | 2011 |
Comparison of cell proliferation, protein, and glucose metabolism in musculoskeletal tumors in a PET study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Bone Neoplasms; Carbon Radioisotopes; | 2011 |
[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male | 2012 |
Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Bone Neoplasms; Child; Choline; Diagnosis, Differential; | 2013 |
Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients.
Topics: Bone and Bones; Bone Neoplasms; Choline; Humans; Male; Multimodal Imaging; Positron-Emission Tomogra | 2012 |
Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
Topics: Aged; Bone Neoplasms; Choline; Fluorides; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male | 2012 |
[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Topics: Aged; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Lymph Node Excision; Lymph Nodes; Lym | 2012 |
[Metabolic and osteogenic pattern of prostate cancer bone metastases].
Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Multimoda | 2013 |
Bone metastases from prostate cancer: 18F-fluoride PET/CT in a patient with discordant bone scintigraphy and 11C-choline PET/CT.
Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorides; Fluorine Radioisotopes; Humans; Male; Mult | 2013 |
Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; False Negative Reactions; Fluorodeoxyglucose F18; Hum | 2002 |
11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Diseases; Bone Neoplasms; Car | 2003 |
Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Choline; Diagnosis, Diff | 2004 |
Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization.
Topics: Bone Neoplasms; Choline; Diagnosis, Differential; Humans; In Vitro Techniques; Magnetic Resonance Sp | 2006 |
C-choline positron emission tomography in bladder cancer: report of four cases.
Topics: Aged; Bone Neoplasms; Carbon Isotopes; Choline; Female; Humans; Male; Middle Aged; Positron-Emission | 2006 |
Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Female; Humans; Male; Middle | 2006 |
18F-choline PET/CT for initial staging of advanced prostate cancer.
Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostat | 2006 |
[18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer.
Topics: Bone Neoplasms; Choline; Hormones; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; | 2007 |
Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
Topics: Adolescent; Adult; Biomarkers; Bone Neoplasms; Choline; Female; Humans; Magnetic Resonance Spectrosc | 2007 |
In vivo proton spectroscopy of giant cell tumor of the bone.
Topics: Adolescent; Adult; Biomarkers, Tumor; Bone Neoplasms; Carcinoma, Giant Cell; Child; Choline; Female; | 2008 |
Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
Topics: Antineoplastic Agents; Bone Neoplasms; Bridged-Ring Compounds; Choline; Down-Regulation; Drug Synerg | 2000 |